Amicar 0.25gm/ml Solution
Overview
What is this medicine?
How to Use This Medicine
To store this medication, keep it at room temperature and avoid freezing. If you miss a dose, contact your doctor for guidance on the best course of action.
Lifestyle & Tips
- Take exactly as prescribed by your doctor. Do not stop taking it without consulting your doctor.
- Measure the liquid medicine carefully using the provided measuring device, not a household spoon.
- Report any unusual bleeding or bruising, or signs of blood clots (e.g., chest pain, shortness of breath, leg swelling) to your doctor immediately.
- Avoid activities that may increase your risk of bleeding or injury while on this medication, unless advised by your doctor.
- Inform all healthcare providers, including dentists, that you are taking this medication.
Available Forms & Alternatives
Available Strengths:
Generic Alternatives:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Abnormal heartbeat or slow heartbeat
Unexplained bruising or bleeding
Swelling
Seizures
Severe dizziness or fainting
Hallucinations (seeing or hearing things that are not there)
Confusion
Weakness on one side of the body, trouble speaking or thinking, balance changes, drooping on one side of the face, or blurred vision
Fever, chills, or sore throat
Changes in vision
Ringing in the ears
Signs of a blood clot, such as:
+ Chest pain or pressure
+ Coughing up blood
+ Shortness of breath
+ Swelling, warmth, numbness, color change, or pain in a leg or arm
+ Trouble speaking or swallowing
This medication can also cause severe muscle problems, which may lead to kidney issues. Inform your doctor if you experience:
Muscle pain or weakness, especially if accompanied by fatigue, weakness, or fever
Difficulty urinating or changes in urine output
Other Possible Side Effects
Like all medications, this drug may cause side effects in some people. Many individuals may not experience any side effects or only minor ones. If you notice any of the following side effects or any other symptoms that concern you or do not go away, contact your doctor:
Headache
Upset stomach or vomiting
Stomach pain or diarrhea
Dizziness, fatigue, or weakness
Nasal congestion
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Signs of a blood clot: sudden chest pain, shortness of breath, coughing up blood, sudden vision changes, sudden numbness or weakness, pain/swelling/warmth in an arm or leg.
- Signs of bleeding: unusual bruising, prolonged bleeding from cuts, nosebleeds, blood in urine (pink or red urine), black or tarry stools, vomiting blood or material that looks like coffee grounds.
- Muscle pain, tenderness, or weakness, especially if accompanied by fever or dark urine (signs of rhabdomyolysis).
- Allergic reaction: rash, itching/swelling (especially of face/tongue/throat), severe dizziness, trouble breathing.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced.
If you have a history of blood clots.
If you are taking any medications that may increase the risk of blood clots, including:
+ Factor IX complex
+ Anti-inhibitor coagulant complex
+ Hormone-based birth control methods
+ Other medications that may interact with this drug (your doctor or pharmacist can help you determine if any of your medications fall into this category)
To ensure your safety, it is crucial to provide your doctor and pharmacist with a comprehensive list of:
All prescription and over-the-counter medications you are taking
Any natural products or vitamins you are using
Your medical history, including any health problems you have
This information will help your doctor determine if it is safe for you to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
Overdose Information
Overdose Symptoms:
- Nausea
- Diarrhea
- Dizziness
- Confusion
- Bradycardia (slow heart rate)
- Hypotension (low blood pressure)
- Acute renal failure
- Thrombosis (blood clot formation)
What to Do:
Seek immediate medical attention or call a poison control center (e.g., 1-800-222-1222). Treatment is supportive and symptomatic. Gastric lavage may be considered if ingestion is recent. Hemodialysis may be effective in removing the drug.
Drug Interactions
Contraindicated Interactions
- Factor IX complex concentrates
- Activated prothrombin complex concentrates (e.g., FEIBA)
Major Interactions
- Oral contraceptives (estrogen-containing)
- Estrogens (systemic)
Moderate Interactions
- Thrombolytic agents (e.g., alteplase, streptokinase, urokinase)
- Tretinoin (oral)
Monitoring
Baseline Monitoring
Rationale: Aminocaproic acid is primarily renally eliminated; impairment can lead to accumulation and toxicity.
Timing: Prior to initiation of therapy.
Rationale: To assess baseline hemostatic status and guide therapy.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Periodically, especially in patients with renal impairment or prolonged therapy.
Target: Within normal limits or stable for patient's baseline.
Action Threshold: Significant increase in BUN/creatinine may warrant dose adjustment or discontinuation.
Frequency: Periodically, as clinically indicated.
Target: Dependent on underlying condition and therapeutic goal.
Action Threshold: Evidence of hypercoagulability or inadequate hemostasis may require intervention.
Frequency: If muscle pain or weakness develops.
Target: Within normal limits.
Action Threshold: Elevated CPK may indicate myopathy/rhabdomyolysis, requiring discontinuation.
Frequency: Periodically, especially with prolonged use.
Target: Absence of hematuria or signs of renal damage.
Action Threshold: Presence of hematuria or red cell casts may indicate glomerular capillary thrombosis.
Symptom Monitoring
- Signs and symptoms of thrombosis (e.g., chest pain, shortness of breath, sudden leg pain/swelling, vision changes, slurred speech)
- Signs and symptoms of bleeding (e.g., excessive bruising, prolonged bleeding from cuts, nosebleeds, blood in urine/stools, black/tarry stools, vomiting blood)
- Muscle pain, weakness, or tenderness (signs of myopathy/rhabdomyolysis)
- Dizziness, lightheadedness
- Nausea, vomiting, diarrhea
- Headache
Special Patient Groups
Pregnancy
Category C. Aminocaproic acid should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Animal studies have shown adverse effects, but there are no adequate and well-controlled studies in pregnant women.
Trimester-Specific Risks:
Lactation
It is not known whether aminocaproic acid is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Pediatric Use
Dosing is established for pediatric patients, but careful weight-based or body surface area-based calculations are crucial. Close monitoring for adverse effects and efficacy is essential.
Geriatric Use
Use with caution in elderly patients, generally starting at the lower end of the dosing range, due to the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy. Renal function should be monitored closely.
Clinical Information
Clinical Pearls
- Aminocaproic acid is primarily used for excessive bleeding due to enhanced fibrinolysis, such as in cardiac surgery, prostatectomy, or certain hematologic disorders.
- It is contraindicated in patients with disseminated intravascular coagulation (DIC) without concomitant heparin, due to the risk of promoting thrombosis.
- Monitor for signs of thrombosis (e.g., DVT, PE, arterial thrombosis) as this is a significant potential adverse effect, especially when used with procoagulant factors.
- Myopathy and rhabdomyolysis have been reported, particularly with prolonged use. Monitor for muscle pain, weakness, and elevated CPK.
- Renal impairment necessitates significant dose adjustment due to renal excretion of the drug.
- Oral solution is useful for patients who cannot swallow tablets or for precise dose adjustments.
Alternative Therapies
- Tranexamic acid (another antifibrinolytic agent, often preferred due to higher potency and longer half-life)